Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Edgewise Therapeutics ( (EWTX) ) just unveiled an update.
On January 8, 2025, Edgewise Therapeutics announced the promotion of Behrad Derakhshan to Chief Operating Officer. Previously the Chief Business Officer, Dr. Derakhshan’s extensive experience in business development within the biotechnology sector is expected to strengthen Edgewise’s operational leadership.
More about Edgewise Therapeutics
Edgewise Therapeutics is a biotechnology company focused on developing treatments for rare diseases.
YTD Price Performance: 1.33%
Average Trading Volume: 802,407
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.59B
See more insights into EWTX stock on TipRanks’ Stock Analysis page.